SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells
- PMID: 40327506
- PMCID: PMC12160121
- DOI: 10.1016/j.celrep.2025.115663
SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells
Abstract
The human immunodeficiency virus (HIV) can persist in a latent form as integrated DNA (provirus) in resting CD4+ T cells unaffected by antiretroviral therapy. Despite being a major obstacle for eradication efforts, it remains unclear which infected cells survive, persist, and ultimately enter the long-lived reservoir. Here, we determine the genetic divergence and integration times of simian immunodeficiency virus (SIV) envelope sequences collected from infected macaques. We show that the proviral divergence and the phylogenetically estimated integration times display a biphasic decline over time. Investigating the dynamics of the mutational distributions, we show that SIV genomes in short-lived cells are, on average, more diverged, while long-lived cells contain less diverged virus. The change in the mutational distributions over time explains the observed biphasic decline in the divergence of the proviruses. This suggests that long-lived cells harbor viruses deposited earlier in infection, while short-lived cells predominantly harbor more recent viruses.
Keywords: CP: Microbiology; HIV; SIV; antiviral treatment; genetic divergence; latency.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests Aspects of HIV-1 IPDA are the subject of patent application PCT/US16/28822 filed by Johns Hopkins University. R.F.S. is an inventor on this application. Accelevir Diagnostics holds an exclusive license for this patent application. R.F.S. holds no equity interest in Accelevir Diagnostics.
Figures
Update of
-
Last in first out: SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells.bioRxiv [Preprint]. 2023 Nov 3:2023.11.03.565539. doi: 10.1101/2023.11.03.565539. bioRxiv. 2023. Update in: Cell Rep. 2025 May 27;44(5):115663. doi: 10.1016/j.celrep.2025.115663. PMID: 37961482 Free PMC article. Updated. Preprint.
References
-
- CDC centers for disease control, HIV and AIDS timeline. https://npin.cdc.gov/pages/hiv-and-aids-timeline, 2022.
-
- WHO world health organization. https://www.who.int/data/gho/data/themes/hiv-aids, 2022.
-
- Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, et al. (1999). Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med 5, 512–517. - PubMed
-
- Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, and Richman DD (1997). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291–1295. - PubMed
MeSH terms
Grants and funding
- R01 OD011095/OD/NIH HHS/United States
- R01 AI087520/AI/NIAID NIH HHS/United States
- P30 AI094189/AI/NIAID NIH HHS/United States
- UM1 AI164561/AI/NIAID NIH HHS/United States
- R01 AI149670/AI/NIAID NIH HHS/United States
- R01 AI028433/AI/NIAID NIH HHS/United States
- P01 AI169615/AI/NIAID NIH HHS/United States
- UM1 AI164556/AI/NIAID NIH HHS/United States
- DP5 OD031834/OD/NIH HHS/United States
- UM1 AI124377/AI/NIAID NIH HHS/United States
- U19 AI128751/AI/NIAID NIH HHS/United States
- UM1 AI164566/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
